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Objective: The Surgical Care Improvement Project (SCIP) is a national initiative to reduce surgical complications,
including postoperative surgical site infection (SSI), through protocol-driven antibiotic usage. This study aimed to
determine the effect SCIP guidelines have had on in-hospital SSIs after open vascular procedures.
Methods: The Nationwide Inpatient Sample (NIS) was retrospectively analyzed using International Classiﬁcation of Dis-
eases, Ninth Revision, diagnosis codes to capture SSIs in hospital patients who underwent elective carotid endarterectomy,
elective open repair of an abdominal aortic aneurysm (AAA), and peripheral bypass. The pre-SCIP era was deﬁned as 2000
to 2005 and post-SCIP was deﬁned as 2007 to 2010. The year 2006 was excluded because this was the transition year in
which the SCIP guidelines were implemented. Analysis of variance and c2 testing were used for statistical analysis.
Results: The rate of SSI in the pre-SCIP era was 2.2% compared with 2.3% for carotid endarterectomy (P [ .06). For
peripheral bypass, both in the pre- and post-SCIP era, infection rates were 0.1% (P [ .22). For open, elective AAA, the
rate of infection in the post-SCIP era increased signiﬁcantly to 1.4% from 1.0% in the pre-SCIP era (P < .001). De-
mographics and in-hospital mortality did not differ signiﬁcantly between the groups.
Conclusions: Implementation of SCIP guidelines has made no signiﬁcant effect on the incidence of in-hospital SSIs in open
vascular operations; rather, an increase in SSI rates in open AAA repairs was observed. Patient-centered, bundled ap-
proaches to care, rather than current SCIP practices, may further decrease SSI rates in vascular patients undergoing open
procedures. (J Vasc Surg 2014;60:1635-9.)The Surgical Care Improvement Project (SCIP) was
created as one of the Joint Commission Core Measures
to improve hospital quality. SCIP is the crux of an ongoing
national initiative to improve the safety and quality of care
provided to patients and is a coordinated effort stemming
from a partnership between the Centers for Medicare and
Medicaid Services (CMS) and the Centers for Disease Con-
trol and Prevention (CDC).1
In 2003, a core measure, “Surgical Infection Preven-
tion,” was initiated and expanded; by July 2006, this mea-
sure, known as “SCIP,” became an integral part of surgical
care.1 SCIP is a function of a steering committee that in-
corporates the CMS, the CDC, the Joint Commission,
and the Agency for Healthcare Research and Quality
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://dx.doi.org/10.1016/j.jvs.2014.08.072mortality and morbidity, ostensibly by 25% within
5 years.”1 In an attempt to fulﬁl this goal, SCIP provided
recommendations on antibiotic use in the preoperative,
perioperative, and postoperative periods to reduce the
rate of surgical site infections (SSIs).
SCIP details explicitly the duration and timing of anti-
biotic prophylaxis to be #60 minutes before incision
(regardless of the surgery type), the type of antibiotic
that is to be given, and insists on the prompt discontinua-
tion of antibiotics postoperatively, especially in elective
cases with no known infective issues. The single dose of an-
tibiotics preoperatively serves to prevent skin or soft tissue
infection that may arise from the incision itself and does not
directly affect organ or peritoneal cavity infections that are
related to the original pathology.
Because SCIP has been linked to ﬁnancial reimburse-
ment by the CMS, mandatory compliance in hospitals
has followed its implementation. The effect of SCIP guide-
lines on vascular SSIs, however, has not been evaluated.
This study aimed to determine the effect of SCIP antibiotic
prescribing practices on in-hospital SSI rates in patients
who underwent open, elective vascular procedures,
including open abdominal aortic aneurysm (AAA) repair,
carotid endarterectomy (CEA), and peripheral bypass.
METHODS
Database and selection. A retrospective analysis was
completed using the Nationwide Inpatient Sample (NIS),
a part of the Health Care Utilization Project (HCUP)1635
Table I. International Classiﬁcation of Diseases, Ninth
Revision (ICD-9), diagnosis and procedure codes used to
select patients fromtheNationwide Inpatient Sample (NIS)
ICD-9 code Description
Diagnosis codes
441.4 AAA without mention of rupture
441.9 Aortic aneurysm, not otherwise speciﬁed
998.59 SSI
Procedure codes
38.34 AAA: aorta resection and anastomosis
38.44 AAA: replacement of abdominal aorta
38.64 AAA: excision of aorta
39.52 AAA: other repair of aneurysm
38.12 CEA: head and neck endarterectomy
39.29 Bypass: vascular shunt and bypass
AAA, Abdominal aortic aneurysm; CEA, carotid endarterectomy; SSI,
surgical site infection.
Table II. Surgical Care Improvement Project (SCIP)
core measure set (implemented in 2006)
Measure ID Description
SCIP Inf-1 Prophylactic antibiotic 1 hour before incision
SCIP Inf-2 Prophylactic antibiotic selection for surgical
patients
SCIP Inf-3 Prophylactic antibiotics discontinued #24 hours
after surgery end time
SCIP Inf-4 Cardiac surgery patients with controlled
postoperative blood glucose
SCIP Inf-6 Surgery patients with appropriate hair removal
(clipping)
SCIP Inf-9 Urinary catheter removed on postoperative day 1
SCIP Inf-10 Surgery patients with perioperative temperature
management
SCIP Card-2 Surgery patients on b-blocker receive b-blocker
perioperatively
SCIP VTE-2 Appropriate venous thromboembolism prophylaxis
24 hours before surgery and 24 hours after
surgery
Inf, Infection; VTE, venous thromboembolism.
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payer inpatient database and includes a stratiﬁed 20%
random sample of all nonfederal inpatient hospital admis-
sions throughout the United States. Clinical records be-
tween 2000 and 2010 were derived using the International
Classiﬁcation of Diseases, Ninth Revision (ICD-9), diag-
nosis and procedure codes to include patients who un-
derwent treatment primarily for elective, open vascular
procedures, including open, elective AAA repair, CEA, and
peripheral bypass with or without SSIs (Table I).2 ICD-9
codes for endovascular AAA repair were excluded
because we could not determine from the ICD-9 codes
which patients underwent a percutaneous endovascular
repair and those who underwent femoral cutdown.
Variables. The independent variable was year, ranging
from 2000 to 2005 and from 2007 to 2010. The year 2006
was excluded because this was the transition year in which
the SCIP guidelines were fully implemented (Table II).1
Demographic covariates included age, gender, and race.
Clinical covariates included SSI, in-hospital mortality, me-
dian length of stay (LOS) in days, and median hospital
charges adjusted for 2010 US dollars using the Consumer
Price Index. Hospital covariates included hospital size,
geographic region, rural vs urban, or teaching vs
nonteaching hospitals. Any patients with pre-existing in-
fections were excluded from the sample. Because this was a
database study, it was exempt from the Investigational
Review Board, and no identiﬁable patient data were used;
hence, no patient consent was necessary.
Statistical analysis. Statistical analysis was completed
using analysis of variance for continuous variables (ie, age)
and c2 for categoric variables (ie, gender, race, and mortal-
ity). The Mann-Whitney U test was used for LOS and total
charges, and the one-tailed c2 test with Yates correction was
used to compare the rate of SSI before and after the initia-
tion of SCIP antibiotic guidelines. Data analysis and man-
agement were completed using SPSS 21.0 software (IBM
Corp, Armonk, NY). Statistical signiﬁcance was set at P <
.05. Values are presented as mean 6 standard deviation for
age or as median values for LOS and total charges. AKendall-Mann trend analysis was completed to assess the
trend in SSI rates during the study period.
RESULTS
The demographics and SSI status of patients who un-
derwent CEA, AAA repair, or peripheral bypass separated
by the development of an SSI in the NIS from 2000 to
2005 are s detailed in Table III. The demographics and
SSI status of patients who underwent CEA, AAA repair,
or peripheral bypass, separated by the development of an
SSI in the NIS from 2007 to 2010 are detailed in Table IV.
There was no difference in demographics, comorbid-
ities, or in-hospital mortality when patients with andwithout
SSI from 2000 to 2005 (pre-SCIP era) were compared with
those with and without SSI from 2007 to 2010 (post-SCIP
era). Furthermore, SSI rates were not affected by hospital
covariates such as hospital size, geographic region, rural vs
urban, or teaching vs nonteaching hospitals.
For CEA, the rate of SSI in the pre-SCIP era was 2.2%
compared with 2.3% in the post-SCIP era (P ¼ .06). In the
peripheral bypass group, the rate of SSI in the pre-SCIP era
was 0.1% and stayed at 0.1% in the post-SCIP era (P ¼
.22). However, for open, elective AAA, the rate of infec-
tion in the post-SCIP era increased signiﬁcantly, from
1.0% in the pre-SCIP era to 1.4% (P < .001). Table V sum-
marizes these results.
The Kendall-Mann trend analysis was completed to
assess the increase in SSI for patients who underwent
open AAA repair in the post-SCIP era compared with the
pre-SCIP era. The analysis found a signiﬁcant increase,
with a correlation coefﬁcient of 0.22 (P < .05).
DISCUSSION
Across the United States w1 million SSIs occur annu-
ally, resulting in 3.7 million extra hospital days and an
added cost in excess of $1.6 billion.3-5 Patients who
develop SSIs are 60% more likely to be admitted to the
Table III. Demographics and surgical site infection (SSI) status of patients who underwent carotid endarterectomy
(CEA), abdominal aortic aneurysm (AAA) repair, or peripheral bypass separated by the development of an SSI in the
Nationwide Inpatient Sample (NIS) from 2000 to 2005
Variable
CEAþ SSI
(n ¼ 254)
CEA SSI
(n ¼ 172,098)
AAAþ SSI
(n ¼ 311)
AAA SSI
(n ¼ 30,205)
Bypassþ SSI
(n ¼ 2386)
Bypass SSI
(n ¼ 106,885)
Age, mean 6 SD, years 71 6 10 71 6 9 72 6 8 72 6 8 67 6 13 68 6 12
Female, % 41 43 28 23 44 41
Caucasian, % 85 90 88 91 73 76
COPD, % 31 20 41 37 24 25
Diabetes mellitus, % 23 25 9 11 18 24
LOS, median (IQR), days 17 (6-25) 2 (1-3) 17 (9-26) 7 (5-10) 17 (10-25) 6 (3-11)
In-hospital mortality, % 12 1 19 4 7 3
Total charges, median
(IQR), $
84,670 ($36,240-
$199,549)
15,139 ($13,401-
$32,852)
102,375 ($39,394-
$172,905)
41,091 ($38,505-
$93,275)
69,877 ($49,142-
$184,710)
30,253 ($23,700-
$74,565)
COPD, Chronic obstructive pulmonary disease; IQR, interquartile range; LOS, length of stay; SD, standard deviation.
Table IV. Demographics and surgical site infection (SSI) status of patients who underwent carotid endarterectomy
(CEA), abdominal aortic aneurysm (AAA) repair, or peripheral bypass separated by the development of an SSI in the
Nationwide Inpatient Sample (NIS) from 2007 to 2010
Variable
CEAþ SSI
(n ¼ 123)
CEA SSI
(n ¼ 91,302)
AAAþ SSI
(n ¼ 134)
AAA SSI
(n ¼ 9163)
Bypassþ SSI
(n ¼ 1243)
Bypass SSI
(n ¼ 52,612)
Age, mean 6 SD, years 70 6 10 71 6 10 71 6 9 71 6 9 66 6 14 67 6 13
Female, % 35 42 30 27 42 37
Caucasian, % 79 88 88 88 75 74
COPD, % 21 22 46 35 25 27
Diabetes mellitus, % 28 28 11 15 17 26
LOS, median (IQR), days 15 (7-28) 1 (1-3) 19 (10-33) 7 (5-10) 15 (8-27) 5 (3-10)
In-hospital mortality, % 7 0 11 4 5 2
Total charges, median
(IQR), $
140,876 ($61,851-
$246,967)
23,236 ($15,977-
$38,798)
159,147 ($72,437-
$363,191)
69,842 ($46,882-
$112,722)
112,726 ($62,539-
$215,503)
49,490 ($29,489-
$89,949)
IQR, Interquartile range; LOS, Length of stay; SD, standard deviation.
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more frequently, and have a two times higher mortality
rate compared with their non-SSI counterparts.3
To decrease rates of surgical complications such as SSI,
SCIP was developed by CMS and implemented in 2006. A
major component of the SCIP initiative focuses on stan-
dardizing timing, type, and duration of antibiotics to
decrease rates of SSI in surgical patients. This protocol-
driven measure was primarily mandated to decrease anti-
biotic administration variation across the nation and
eliminate institutional error rates related to antibiotic
timing and duration.4,5
Open vascular procedures are considered “clean” cases
and warrant a single dose of cefazolin 60 minutes before
incision for most surgical procedures, according to SCIP
guidelines. Cefazolin has been used for vascular procedures
since 1978 when Kaiser et al6 reported a decrease in SSIs in
patients administered preoperative cefazolin compared with
placebo. However, before the SCIP initiative, some vascular
surgeons administered additional doses of cefazolin after the
procedure or included other antibiotics, such as ampicillin/
sulbactam, or both. With the surge of methicillin-resistant
Staphylococcus aureus (MRSA), studies have attempted to
decipher if additional antibiotics or routineMRSA screening
with prophylaxis decreases infection rates.7,8 These studiesconcluded that adding anti-MRSA agents to current antibi-
otic regimens did not reduce rates and that up to 57% of pa-
tients who developed an MRSA infection were MRSA-free
on admission, making screening futile.7,8
These data, in conjunction with the fact that hospital
adherence to SCIP quality care measures is directly linked
to hospital reimbursement, have ensured that SCIP proto-
cols in their current form are implemented nationally.1
These SCIP initiatives are expensive to implement and
require a multidisciplinary approach to achieve the neces-
sary 95% compliance with core measures.4,5,9 Hence, deter-
mining if these SCIP measures are indeed positively
affecting surgical complication rates and are therefore
cost-effective is important. Our results, which showed no
improvement in the SSI rate for CEA or open bypass along
with an increase in the SSI rate in open AAA repair, would
seem to suggest that SCIP has not had a positive effect in
this area as hoped.
With few exceptions made for colorectal or cardiovascu-
lar surgery, SCIP guidelines are universally applied to pa-
tients who undergo surgical procedures. Hawn et al10
found that SSI risk varies by patient characteristics and by
procedural type; hence, applying SCIP guidelines in their
current form to all-comers undergoing open vascular proce-
dures may be inappropriate.7,10 Several factors have been
Table V. Breakdown of surgical site infections (SSIs) by year between 2000 and 2005 and between 2007and 2010 for
patients who underwent carotid endarterectomy (CEA), elective repair of an unruptured abdominal aortic aneurysm
(AAA), and peripheral bypassa
Procedure 2000 2001 2002 2003 2004 2005 2007 2008 2009 2010
CEA
SSI 446 384 435 412 369 340 364 328 300 251
Total 20,230 19,700 19,539 18,062 16,558 15,183 13,999 14,193 13,354 12,311
% 2.2 1.9 2.2 2.3 2.2 2.2 2.6 2.3 2.2 2.0
AAAb
SSI 51 52 60 57 50 41 45 20 42 27
Total 7572 5563 4958 4698 4156 3570 2616 2597 2302 1782
% 0.7 0.9 1.2 1.2 1.2 1.1 1.7 0.8 1.8 1.5
Bypass
SSI 42 35 48 44 37 48 36 39 29 19
Total 30,277 30,190 30,979 29,440 26,285 25,188 24,628 24,541 22,592 19,665
% 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1
aPooled values between 2000 and 2005 and between 2007 and 2010 were compared using c2 with Yates correction, with P < .05 indicating signiﬁcance.
bP < .05.
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site location, body mass index (BMI), adherence to anti-
septic shower requirements, maximum intraoperative blood
glucose level, and the length of operation or hospital stay.7
Furthermore, vascular interventions may directly affect the
rate of blood ﬂow to the area, which may increase the risk
of infection and healing propensity.
Patients undergoing open AAA surgery are subject to a
long operation time, periods of hypotension, and bowel
manipulation that may put them at increased risk of SSIs.
Our results show that patients with open AAA repair had
an increase in in-hospital SSI rates after the SCIP guidelines
were implemented, illustrating the notion that the “one
size ﬁts all” dictum of SCIP is perhaps not adequate and
potentially harmful in this patient population.
The overall success of SCIP has been varied. Colorectal
studies have reported data that shows increased compliance
with SCIP measures does not correlate with a decrease in
SSI.11 Stulberg et al12 reported an increase in infection rates
for colorectal patients with increased compliance with SCIP
measures during a 2-year period. There are two possible rea-
sons for an increase in infection rates even with adherence to
SCIP measures. A pharmacokinetic study found that in pa-
tients with a BMI>40 kg/m2, the standard 2 grams of cefa-
zolin in conjunction with appropriate redosing at 3 hours
was insufﬁcient to achieve therapeutic levels of the antibiotic
in tissue.4,5,9 Current SCIP guidelines do not incorporate
patient factors such as BMI into dosing regimens.
Another possibility is the evolving antibiotic resistance
patterns within the United States. Studies have found
Escherichia coli has decreased susceptibility to ﬁrst-
generation cephalosporin antibiotics, likely due to
increased use of the drug. The efﬁcacy of cefazolin, the cur-
rent SCIP drug of choice, has diminished during the last
20 years, which may account for SSI rate results.4,5,9
Our results indicate that a “one-size ﬁts all” antibiotic
approach mandated by SCIP, with signiﬁcant reimburse-
ment implications, may be inappropriate for some open
vascular procedures. Instead, a patient-centered “bundleapproach” may be a better strategy to decrease SSI rates
in vascular patients undergoing procedures. Our study
also noted that charges have substantially increased in pa-
tients with SSIs between the pre-SCIP and post-SCIP era
and primarily reﬂect the increased LOS and additional in-
terventions that are necessary in these patients.
Waits et al13 described a bundled approach to care in a
multi-institutional study of colorectal patients that included
points for normothermia, SCIP-delineated antibiotic pro-
phylaxis, bowel preparation, perioperative glycemic control,
minimally invasive surgery, and a short operation duration.
The authors reported a low 2% infection rate for patients
that met all of the bundle score criteria and up to a 17.5%
infection rate for patients that met only one element of
the score.13 Perhaps a bundled score for open vascular sur-
gery operations may achieve a similar lower SSI rate in the
open AAA population. This would include timely antibiotic
prophylaxis, antiseptic showering, glycemic control perio-
peratively, normothermia, and adequate alcohol-based
skin preparation before the incision.4,5,9
This study is limited by its retrospective design and use
of a database. Although the NIS-HCUP is a validated data-
base constructed by the federal government to evidence de-
cision making and health care policy, data are entered based
on ICD-9 codes, which has inherent ﬂaws. Given that only
hospital admission data are entered, long-term follow-up of
patients is not possible; hence, the infection rates reported in
this study are that of the in-patient admission in which the
surgery occurred. We thus may have under-reported overall
SSI rates given that a patient may return as an out patient
with a SSI not noted before the initial discharge.
Another limitation is that because of the deidentiﬁed
database nature of this study, determining exactly how
adherent hospitals were to SCIP guidelines >2006 is not
possible. Exclusion of the year 2006 was an attempt to miti-
gate this limitation because most hospitals by the end of the
2006would be adhering to SCIPguidelines to ensure appro-
priate reimbursement. TheNIS does not track readmissions,
and it is likely that some of the patients who developed SSI
JOURNAL OF VASCULAR SURGERY
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wound infections and hence were not captured.
Second, the NIS does not track outpatient visits, and so
patients who were seen as outpatients would not have been
captured as part of this sample.
Finally, some comorbidities, including renal failure and
the presence of tissue loss, that have been associated with
SSI after infrainguinal bypass were not included because
the NIS is limited by the data available in the time periods
reviewed. The urgency of operative procedures was not
identiﬁable in the patient data set.
CONCLUSIONS
Implementation of SCIP guidelines has made no sig-
niﬁcant effect on the incidence of SSI in open vascular op-
erations, including CEA or peripheral bypass. An increase
in SSI rates in open, elective AAA repairs was observed in
the post-SCIP era compared with the pre-SCIP era. These
data suggest that the current approach to antibiotic admin-
istration in surgical patients may be inadequate for some
vascular procedures and that a more patient-centric
approach that takes into account factors, including the anti-
biotic resistance patterns of the hospital, glucose control,
and weight, may be more suitable for patients undergoing
open vascular surgery.
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